Cargando…

Preoperative adjuvant therapy for locally advanced and recurrent/metastatic gastrointestinal stromal tumors: a retrospective study

BACKGROUND: Preoperative imatinib mesylate therapy for gastrointestinal stromal tumors (GISTs) is controversial. This study aimed to explore the clinical efficacy and optimal duration of preoperative imatinib mesylate (IM) therapy in patients with locally advanced and recurrent/metastatic GISTs. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Jing, Liu, He-Li, Ren, Feng, Liu, Sheng, Shi, Wei, Liu, Wei-Hang, Cai, Gao-Qiang, Liao, Guo-Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140320/ https://www.ncbi.nlm.nih.gov/pubmed/32264886 http://dx.doi.org/10.1186/s12957-020-01840-9

Ejemplares similares

Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors: A single-center analysis
por: Wang, Jian, et al.
Publicado: (2020)

Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor
por: Shen, Chaoyong, et al.
Publicado: (2014)

Long-term adjuvant imatinib treatment for a patient who underwent complete resection of a localized recurrent gastrointestinal stromal tumor after preoperative imatinib treatment: A case report
por: Tjhoi, Welda E.H., et al.
Publicado: (2019)

Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumor
por: Ling, Jiayu, et al.
Publicado: (2023)

The Use of Molecular Subtypes for Precision Therapy of Recurrent and Metastatic Gastrointestinal Stromal Tumor
por: Liu, Peng, et al.
Publicado: (2020)

Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib
por: Joensuu, Heikki, et al.
Publicado: (2014)

Using the recurrence risk score by Joensuu to assess patients with gastrointestinal stromal tumor treated with adjuvant imatinib: A retrospective cohort study
por: Tang, Jianwei, et al.
Publicado: (2018)

Apatinib Treatment in Metastatic Gastrointestinal Stromal Tumor
por: Cai, Zhaolun, et al.
Publicado: (2019)

Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib
por: Chang, Shih-Chun, et al.
Publicado: (2016)

Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors
por: Iwatsuki, Masaaki, et al.
Publicado: (2018)

Downregulation of miR-186 is associated with metastatic recurrence of gastrointestinal stromal tumors
por: Niinuma, Takeshi, et al.
Publicado: (2017)

Survival outcome of local versus radical resection for jejunoileal gastrointestinal stromal tumors: a propensity score-matched population-based analysis
por: Yan, Shangcheng, et al.
Publicado: (2023)

Preoperative prediction of gastrointestinal stromal tumors with high Ki-67 proliferation index based on CT features
por: Yang, Cai-Wei, et al.
Publicado: (2021)

External beam radiation therapy for locally advanced and metastatic gastrointestinal stromal tumors
por: Cuaron, John J, et al.
Publicado: (2013)

Long-term Results of Adjuvant Imatinib Treatment for Localized Gastrointestinal Stromal Tumors after Surgery
por: Aznab, Mozaffar, et al.
Publicado: (2018)

Optimizing Adherence to Adjuvant Imatinib in Gastrointestinal Stromal Tumor
por: Tetzlaff, Eric D., et al.
Publicado: (2013)

Gastrointestinal Stromal Tumors: How to Increase the Preoperative Endoscopic Ultrasonography Diagnostic Rate
por: Chu, Chia-Sheng
Publicado: (2018)

Ghrelin and gastrointestinal stromal tumors
por: Zhu, Chang-Zhen, et al.
Publicado: (2017)

Surgical resection for patients with recurrent or metastatic gastrointestinal stromal tumors: a protocol for a systematic review and meta-analysis update
por: Cai, Zhaolun, et al.
Publicado: (2021)

Adjuvant Imatinib Treatment for 5 Years versus 3 Years in Patients with Ruptured Localized Gastrointestinal Stromal Tumor: A Retrospective Analysis
por: Kang, Sora, et al.
Publicado: (2022)

Nomogram for Predicting Recurrence-Free Survival of Primary Localized Gastrointestinal Stromal Tumor
por: Ran, Pan, et al.
Publicado: (2023)

Nomogram to Predict Preoperative Occult Peritoneal Metastasis of Gastrointestinal Stromal Tumors (GIST) Based on Imaging and Inflammatory Indexes
por: Xu, Shao-Jun, et al.
Publicado: (2020)

Adjuvant imatinib for patients with high-risk gastrointestinal stromal tumors: a retrospective cohort study
por: Zhao, Rui, et al.
Publicado: (2017)

The Merendino procedure following preoperative imatinib mesylate for locally advanced gastrointestinal stromal tumor of the esophagogastric junction
por: Staiger, Wilko I, et al.
Publicado: (2008)

Radiological Features of Metastatic Gastrointestinal Stromal Tumors
por: Patnaik, Sujata, et al.
Publicado: (2012)

Survival outcome of local vs. radical excision in rectal gastrointestinal stromal tumor: a SEER database analysis
por: Wei, Jianchang, et al.
Publicado: (2022)

Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)
por: Nilsson, B, et al.
Publicado: (2007)

Personalized CT-based radiomics nomogram preoperative predicting Ki-67 expression in gastrointestinal stromal tumors: a multicenter development and validation cohort
por: Zhang, Qing-Wei, et al.
Publicado: (2020)

Prognostic impact of gastrointestinal bleeding and expression of PTEN and Ki-67 on primary gastrointestinal stromal tumors
por: Wang, Hao, et al.
Publicado: (2014)

Prognostic impact of preoperative neutrophil–lymphocyte ratio for surgically resected gastrointestinal stromal tumors
por: Yang, Jing, et al.
Publicado: (2019)

Personalized Dose of Adjuvant Imatinib in Patients with Gastrointestinal Stromal Tumors: Results from a Population Pharmacokinetic Analysis
por: Jiang, Xuehui, et al.
Publicado: (2023)

Cytoreductive surgery offers prognostic benefits in metastatic gastrointestinal stromal tumors with generalized progression following imatinib therapy: a single institute retrospective study
por: Liu, Dao-Ning, et al.
Publicado: (2023)

Subsequent intra-abdominal fibromatosis mimicking recurrent gastrointestinal stromal tumor
por: Jiang, Dongxian, et al.
Publicado: (2013)

Preoperative CT-Based Deep Learning Model for Predicting Risk Stratification in Patients With Gastrointestinal Stromal Tumors
por: Kang, Bing, et al.
Publicado: (2021)

Postoperative Adjuvant Imatinib Therapy-Associated Nomogram to Predict Overall Survival of Gastrointestinal Stromal Tumor
por: Liu, Xuechao, et al.
Publicado: (2022)

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
por: Tang, Sumin, et al.
Publicado: (2017)

A Case Report of a Metastatic Gastrointestinal Stromal Tumor Occurring in Femur
por: Zheng, Chang-kun, et al.
Publicado: (2011)

The Value of Endoscopic Ultrasonography in the Endoscopic Resection of Gastrointestinal Stromal Tumors
por: Mi, Jian-Wei, et al.
Publicado: (2021)

Risk Factors and Prognostic Analysis of Gastrointestinal Stromal Tumor Recurrence-Metastasis
por: Chen, Shan, et al.
Publicado: (2022)

Gastrointestinal stromal tumor: 15-years’ experience in a single center
por: Wang, Ming, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l6rs07mndq96kum4vj22fdnh7c